Major congenital anomalies in a Danish region

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Major congenital anomalies in a Danish region. / Garne, Ester; Hansen, Anne Vinkel; Birkelund, Anne Sofie; Andersen, Anne-Marie Nybo.

In: Danish Medical Journal, Vol. 61, No. 6, A4825, 06.2014, p. 1-5.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Garne, E, Hansen, AV, Birkelund, AS & Andersen, A-MN 2014, 'Major congenital anomalies in a Danish region', Danish Medical Journal, vol. 61, no. 6, A4825, pp. 1-5.

APA

Garne, E., Hansen, A. V., Birkelund, A. S., & Andersen, A-M. N. (2014). Major congenital anomalies in a Danish region. Danish Medical Journal, 61(6), 1-5. [A4825].

Vancouver

Garne E, Hansen AV, Birkelund AS, Andersen A-MN. Major congenital anomalies in a Danish region. Danish Medical Journal. 2014 Jun;61(6):1-5. A4825.

Author

Garne, Ester ; Hansen, Anne Vinkel ; Birkelund, Anne Sofie ; Andersen, Anne-Marie Nybo. / Major congenital anomalies in a Danish region. In: Danish Medical Journal. 2014 ; Vol. 61, No. 6. pp. 1-5.

Bibtex

@article{4c5e099d68f946298dccb642264308a7,
title = "Major congenital anomalies in a Danish region",
abstract = "INTRODUCTION: This study describes the prevalence of congenital anomalies and changes over time in birth outcome, mortality and chronic maternal diseases.MATERIAL AND METHODS: This study was based on population data from the EUROCAT registry covering the Funen County, Denmark, 1995-2008. The registry covers live births, foetal deaths with a gestational age (GA) of 20 weeks or more, and terminations of pregnancy due to congenital anomalies (TOPFA).RESULTS: The overall prevalence of congenital anomalies was 2.70{\%} (95{\%} confidence interval: 2.58-2.80). The majority of cases had an isolated congenital anomaly, 13.9{\%} had a chromosomal anomaly and 7.7{\%} were multiple congenital anomalies. The combined foetal and infant mortality in the study area was 11.6 per 1,000 births. 19{\%} (2.2 per 1,000) of these deaths were foetuses and infants with major congenital anomalies. Combined foetal and infant mortality decreased significantly over time for cases with major congenital anomalies (p < 0.001), whereas the number and proportion of TOPFA increased. Median GA at TOPFA decreased from 18 to 15 weeks. Among the congenital anomaly cases, 8{\%} had a registration of one of these chronic maternal diseases: diabetes, epilepsy, mental disorder, thyroid disease, asthma, or inflammatory bowel disease. Medication for these conditions accounted for 46{\%} of maternal drug use.CONCLUSION: Maternal morbidity and use of potentially teratogenic medication have increased among congenital anomaly cases. Foetal and infant mortality for congenital anomaly cases have decreased significantly, probably owing to an increase in early prenatal diagnosis and TOPFA.FUNDING: The study was funded by Region of South Denmark.TRIAL REGISTRATION: not relevant.",
author = "Ester Garne and Hansen, {Anne Vinkel} and Birkelund, {Anne Sofie} and Andersen, {Anne-Marie Nybo}",
year = "2014",
month = "6",
language = "English",
volume = "61",
pages = "1--5",
journal = "Danish Medical Journal",
issn = "1603-9629",
publisher = "Almindelige Danske Laegeforening",
number = "6",

}

RIS

TY - JOUR

T1 - Major congenital anomalies in a Danish region

AU - Garne, Ester

AU - Hansen, Anne Vinkel

AU - Birkelund, Anne Sofie

AU - Andersen, Anne-Marie Nybo

PY - 2014/6

Y1 - 2014/6

N2 - INTRODUCTION: This study describes the prevalence of congenital anomalies and changes over time in birth outcome, mortality and chronic maternal diseases.MATERIAL AND METHODS: This study was based on population data from the EUROCAT registry covering the Funen County, Denmark, 1995-2008. The registry covers live births, foetal deaths with a gestational age (GA) of 20 weeks or more, and terminations of pregnancy due to congenital anomalies (TOPFA).RESULTS: The overall prevalence of congenital anomalies was 2.70% (95% confidence interval: 2.58-2.80). The majority of cases had an isolated congenital anomaly, 13.9% had a chromosomal anomaly and 7.7% were multiple congenital anomalies. The combined foetal and infant mortality in the study area was 11.6 per 1,000 births. 19% (2.2 per 1,000) of these deaths were foetuses and infants with major congenital anomalies. Combined foetal and infant mortality decreased significantly over time for cases with major congenital anomalies (p < 0.001), whereas the number and proportion of TOPFA increased. Median GA at TOPFA decreased from 18 to 15 weeks. Among the congenital anomaly cases, 8% had a registration of one of these chronic maternal diseases: diabetes, epilepsy, mental disorder, thyroid disease, asthma, or inflammatory bowel disease. Medication for these conditions accounted for 46% of maternal drug use.CONCLUSION: Maternal morbidity and use of potentially teratogenic medication have increased among congenital anomaly cases. Foetal and infant mortality for congenital anomaly cases have decreased significantly, probably owing to an increase in early prenatal diagnosis and TOPFA.FUNDING: The study was funded by Region of South Denmark.TRIAL REGISTRATION: not relevant.

AB - INTRODUCTION: This study describes the prevalence of congenital anomalies and changes over time in birth outcome, mortality and chronic maternal diseases.MATERIAL AND METHODS: This study was based on population data from the EUROCAT registry covering the Funen County, Denmark, 1995-2008. The registry covers live births, foetal deaths with a gestational age (GA) of 20 weeks or more, and terminations of pregnancy due to congenital anomalies (TOPFA).RESULTS: The overall prevalence of congenital anomalies was 2.70% (95% confidence interval: 2.58-2.80). The majority of cases had an isolated congenital anomaly, 13.9% had a chromosomal anomaly and 7.7% were multiple congenital anomalies. The combined foetal and infant mortality in the study area was 11.6 per 1,000 births. 19% (2.2 per 1,000) of these deaths were foetuses and infants with major congenital anomalies. Combined foetal and infant mortality decreased significantly over time for cases with major congenital anomalies (p < 0.001), whereas the number and proportion of TOPFA increased. Median GA at TOPFA decreased from 18 to 15 weeks. Among the congenital anomaly cases, 8% had a registration of one of these chronic maternal diseases: diabetes, epilepsy, mental disorder, thyroid disease, asthma, or inflammatory bowel disease. Medication for these conditions accounted for 46% of maternal drug use.CONCLUSION: Maternal morbidity and use of potentially teratogenic medication have increased among congenital anomaly cases. Foetal and infant mortality for congenital anomaly cases have decreased significantly, probably owing to an increase in early prenatal diagnosis and TOPFA.FUNDING: The study was funded by Region of South Denmark.TRIAL REGISTRATION: not relevant.

M3 - Journal article

C2 - 24947618

VL - 61

SP - 1

EP - 5

JO - Danish Medical Journal

JF - Danish Medical Journal

SN - 1603-9629

IS - 6

M1 - A4825

ER -

ID: 120537465